JW Pharmaceutical Corp Free Cash Flow Generation Index
JW Pharmaceutical Corp free cash flow generation index. JW Pharmaceutical Corp (001067) has a Free Cash Flow Generation Index of 0.79x as of September 2025. Free cash flow of ₩37.12 Billion represents 1% of operating cash flow (₩46.92 Billion).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of JW Pharmaceutical Corp (2014–2024)
Free cash flow generation index of JW Pharmaceutical Corp from 2014 to 2024. Historical FCF Generation Index trend for JW Pharmaceutical Corp across 10 annual periods. See financial agility of JW Pharmaceutical Corp to measure the company's free cash flow as a share of total liabilities.
JW Pharmaceutical Corp Free Cash Flow Generation Index by Year (2014–2024)
JW Pharmaceutical Corp free cash flow generation index by year from 2014 to 2024. Year-by-year Free Cash Flow Generation Index for JW Pharmaceutical Corp. For the full cash flow conversion analysis, see how efficiently does JW Pharmaceutical Corp generate cash.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.65x | ₩51.25 Billion | ₩79.39 Billion | ₩28.14 Billion | ▲ +21.1% |
| 2023 | 0.53x | ₩46.45 Billion | ₩87.16 Billion | ₩40.71 Billion | ▼ -31.9% |
| 2022 | 0.78x | ₩44.41 Billion | ₩56.76 Billion | ₩9.92 Billion | ▲ +171.5% |
| 2021 | 0.29x | ₩5.22 Billion | ₩18.12 Billion | ₩7.47 Billion | ▼ -62.2% |
| 2020 | 0.76x | ₩48.02 Billion | ₩63.05 Billion | ₩12.39 Billion | ▼ -0.3% |
| 2019 | 0.76x | ₩42.43 Billion | ₩55.53 Billion | ₩9.28 Billion | ▼ -9.0% |
| 2018 | 0.84x | ₩43.76 Billion | ₩52.11 Billion | ₩8.64 Billion | ▲ +24.9% |
| 2017 | 0.67x | ₩22.50 Billion | ₩33.45 Billion | ₩7.50 Billion | ▼ -73.0% |
| 2016 | 2.49x | ₩16.76 Billion | ₩6.74 Billion | ₩10.02 Billion | ▲ +27.4% |
| 2014 | 1.95x | ₩14.21 Billion | ₩7.28 Billion | ₩6.93 Billion | — |